Legend Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Market Capitalization	10,935	10,938	7,705	6,774	3,643	-	Upgrade
Market Cap Growth	28.19%	41.96%	13.75%	85.96%	-	-	Upgrade
Enterprise Value	9,739	9,958	6,963	6,013	3,140	-153	Upgrade
PE Ratio	-	-21.11	-17.26	-16.78	-13.67	-	Upgrade
PS Ratio	31.24	38.36	65.85	98.42	48.57	-	Upgrade
PB Ratio	9.20	8.74	10.35	8.84	13.00	-	Upgrade
P/FCF Ratio	-31.57	-23.76	-30.55	-33.95	-14.03	-	Upgrade
P/OCF Ratio	-34.47	-24.89	-36.68	-33.95	-15.61	-	Upgrade
EV/Sales Ratio	28.41	34.92	59.51	87.37	41.86	-2.55	Upgrade
EV/EBITDA Ratio	-	-20.84	-16.72	-15.32	-10.67	1.26	Upgrade
EV/EBIT Ratio	-20.72	-19.98	-16.01	-14.80	-10.33	1.20	Upgrade
EV/FCF Ratio	-28.57	-21.63	-27.60	-30.14	-12.10	1.48	Upgrade
Debt / Equity Ratio	0.29	0.26	0.38	0.16	0.01	-0.05	Upgrade
Debt / EBITDA Ratio	-	-0.69	-0.68	-0.31	-0.01	-0.05	Upgrade
Debt / FCF Ratio	-1.04	-0.71	-1.13	-0.62	-0.01	-0.06	Upgrade
Quick Ratio	5.23	6.51	3.45	4.08	3.61	1.48	Upgrade
Current Ratio	5.66	6.92	3.69	4.14	3.68	1.62	Upgrade
Asset Turnover	0.19	0.17	0.10	0.08	0.15	0.17	Upgrade
Interest Coverage	-20.12	-22.87	-40.29	-451.44	-72.24	-569.94	Upgrade
Return on Equity (ROE)	-36.10%	-44.60%	-59.10%	-105.00%	-338.50%	177.90%	Upgrade
Return on Assets (ROA)	-25.20%	-30.40%	-36.40%	-47.20%	-52.80%	-28.30%	Upgrade
Return on Capital (ROIC)	-21.47%	-24.31%	-43.35%	-43.98%	-78.89%	108.64%	Upgrade
Earnings Yield	-4.35%	-4.74%	-5.79%	-5.96%	-7.31%	-	Upgrade
FCF Yield	-3.02%	-4.21%	-3.27%	-2.95%	-7.13%	-	Upgrade
Buyback Yield / Dilution	-10.08%	-10.71%	-12.91%	-19.21%	-18.15%	-	Upgrade
Total Shareholder Return	-10.08%	-10.71%	-12.91%	-19.21%	-18.15%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).